BG104865A - Paroxetinne-containing compositions - Google Patents
Paroxetinne-containing compositionsInfo
- Publication number
- BG104865A BG104865A BG104865A BG10486500A BG104865A BG 104865 A BG104865 A BG 104865A BG 104865 A BG104865 A BG 104865A BG 10486500 A BG10486500 A BG 10486500A BG 104865 A BG104865 A BG 104865A
- Authority
- BG
- Bulgaria
- Prior art keywords
- paroxetinne
- containing compositions
- paroxetine
- adsorbed
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Paroxetine is adsorbed on a carrier to form a free-flowing powder useful for capsule filling or for tablet formation; and used in therapy to treat depression. 9 claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9806312.6A GB9806312D0 (en) | 1998-03-24 | 1998-03-24 | Novel formulations |
PCT/GB1999/000922 WO1999048499A1 (en) | 1998-03-24 | 1999-03-24 | Paroxetine compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BG104865A true BG104865A (en) | 2001-05-31 |
Family
ID=10829181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG104865A BG104865A (en) | 1998-03-24 | 2000-10-16 | Paroxetinne-containing compositions |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1063993A1 (en) |
JP (1) | JP2002507569A (en) |
CN (1) | CN1125639C (en) |
AP (1) | AP2000001914A0 (en) |
AU (1) | AU754765B2 (en) |
BG (1) | BG104865A (en) |
BR (1) | BR9908991A (en) |
CA (1) | CA2324612A1 (en) |
EA (1) | EA003393B1 (en) |
GB (1) | GB9806312D0 (en) |
HU (1) | HUP0101326A3 (en) |
ID (1) | ID26485A (en) |
IL (1) | IL138478A0 (en) |
NO (1) | NO313404B1 (en) |
NZ (1) | NZ506893A (en) |
PL (1) | PL343095A1 (en) |
SK (1) | SK14102000A3 (en) |
TR (1) | TR200002750T2 (en) |
WO (1) | WO1999048499A1 (en) |
ZA (1) | ZA200005697B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9914600D0 (en) * | 1999-06-22 | 1999-08-25 | Smithkline Beecham Plc | Novel,process |
DK200100341A (en) * | 2001-03-02 | 2002-09-03 | Gea Farmaceutisk Fabrik As | Process for the preparation of pharmaceutical tablets containing paroxetine hydrochloride anhydrate |
CA2531097C (en) * | 2003-07-02 | 2012-10-09 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
US8062664B2 (en) | 2003-11-12 | 2011-11-22 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
HU1000278D0 (en) * | 2010-05-28 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | Novel pharmaceutical use uf silicic acid |
CN103961333B (en) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | Paroxetine mesylate capsule and preparation method thereof |
CN104027306A (en) * | 2014-06-25 | 2014-09-10 | 万特制药(海南)有限公司 | Paroxetine oral suspension and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
ES2058061T3 (en) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT. |
SK283608B6 (en) * | 1995-02-06 | 2003-10-07 | Smithkline Beecham Plc | New forms of parotexin hydrochloride |
CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
-
1998
- 1998-03-24 GB GBGB9806312.6A patent/GB9806312D0/en not_active Ceased
-
1999
- 1999-03-24 TR TR2000/02750T patent/TR200002750T2/en unknown
- 1999-03-24 BR BR9908991-2A patent/BR9908991A/en not_active IP Right Cessation
- 1999-03-24 NZ NZ506893A patent/NZ506893A/en unknown
- 1999-03-24 CA CA002324612A patent/CA2324612A1/en not_active Abandoned
- 1999-03-24 HU HU0101326A patent/HUP0101326A3/en unknown
- 1999-03-24 EA EA200000977A patent/EA003393B1/en not_active IP Right Cessation
- 1999-03-24 AP APAP/P/2000/001914A patent/AP2000001914A0/en unknown
- 1999-03-24 ID IDW20001883A patent/ID26485A/en unknown
- 1999-03-24 EP EP99911940A patent/EP1063993A1/en not_active Withdrawn
- 1999-03-24 CN CN99804347A patent/CN1125639C/en not_active Expired - Fee Related
- 1999-03-24 IL IL13847899A patent/IL138478A0/en unknown
- 1999-03-24 SK SK1410-2000A patent/SK14102000A3/en unknown
- 1999-03-24 WO PCT/GB1999/000922 patent/WO1999048499A1/en not_active Application Discontinuation
- 1999-03-24 PL PL99343095A patent/PL343095A1/en unknown
- 1999-03-24 JP JP2000537547A patent/JP2002507569A/en active Pending
- 1999-03-24 AU AU30451/99A patent/AU754765B2/en not_active Withdrawn - After Issue
-
2000
- 2000-09-22 NO NO20004740A patent/NO313404B1/en unknown
- 2000-10-16 BG BG104865A patent/BG104865A/en unknown
- 2000-10-16 ZA ZA200005697A patent/ZA200005697B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA200000977A1 (en) | 2001-02-26 |
CA2324612A1 (en) | 1999-09-30 |
SK14102000A3 (en) | 2001-03-12 |
NO20004740D0 (en) | 2000-09-22 |
NO20004740L (en) | 2000-10-03 |
JP2002507569A (en) | 2002-03-12 |
EA003393B1 (en) | 2003-04-24 |
CN1294512A (en) | 2001-05-09 |
CN1125639C (en) | 2003-10-29 |
PL343095A1 (en) | 2001-07-30 |
ID26485A (en) | 2001-01-11 |
NZ506893A (en) | 2003-06-30 |
TR200002750T2 (en) | 2000-12-21 |
GB9806312D0 (en) | 1998-05-20 |
AU754765B2 (en) | 2002-11-21 |
HUP0101326A3 (en) | 2002-06-28 |
BR9908991A (en) | 2000-12-12 |
AP2000001914A0 (en) | 2000-09-30 |
WO1999048499A1 (en) | 1999-09-30 |
IL138478A0 (en) | 2001-10-31 |
EP1063993A1 (en) | 2001-01-03 |
ZA200005697B (en) | 2001-10-02 |
HUP0101326A2 (en) | 2002-05-29 |
AU3045199A (en) | 1999-10-18 |
NO313404B1 (en) | 2002-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0818991A4 (en) | Controlled release insufflation carrier for medicaments | |
MY121397A (en) | Ziprasidone formulations | |
MX9700223A (en) | Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension. | |
IL110045A (en) | Pharmaceutical compositions containing oligopeptides for combating AIDS and ARC and for immune stimulation and certain such novel oligopeptides | |
HUT75648A (en) | 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and pharmaceutical compositions containing them | |
GEP20022752B (en) | Valaciclovir Tablets Containing Colloidal Silicon Dioxide | |
CA2284663A1 (en) | Rapidly dissolving robust dosage form | |
IL136285A0 (en) | Pharmaceutical compositions containing an acid-labile active component | |
MY128809A (en) | Pharmaceutical formulation of omeprazole | |
EP1004310A4 (en) | Gelled composition | |
HUP0101568A3 (en) | Substituted indolinones having an inhibiting effect on kinases and cycline/cdk complexes, pharmaceutical compositions containing them and process for producing them | |
GB2367004B (en) | A cyclosporin containing composition in the form of a capsule | |
NZ336592A (en) | Formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising finely divided budesonide and a carrier | |
BG104865A (en) | Paroxetinne-containing compositions | |
MY106371A (en) | Oral pharmaceutical compositions in unit dosage form | |
BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
NZ504418A (en) | Delayed release oral dosage form of carvedilol | |
MY115533A (en) | Benzothiophenes, formulation containing same and methods | |
ES8707488A1 (en) | Biologically active ketone derivative, preparation and use. | |
MX9709838A (en) | Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions. | |
HK1056315A1 (en) | Use of bifidobacteria in manufacture of medicaments for preventing diarrhea. | |
MD970269A (en) | Clavulanates | |
HUT49320A (en) | Process for producing ornithine derivatives and pharmaceutical compositions containing them as active components | |
GB2218711B (en) | Process for producing powdered inorganic compounds and metal compositions. | |
HU9402648D0 (en) | 3,4-dioxo-1-cyclobuten-1-yl-substituted (indolyl-alkyl)-pyridine- and -pyrimidine derivatives and antimigraine composition containing them as active componens |